The Column Group
Dr. Stone joined The Column Group in 2022 to assist the firm’s portfolio companies in recruiting their scientific teams. Prior to joining the firm, Dr. Stone built out the team and labs as Head of People and Operations for BridgeBioX, the early discovery arm of BridgeBio. Dr. Stone worked in talent and operations at Verge Genomics, growing the team from 10-25. Her interest in building strong startup teams began while working for Recruitomics Talent Lab, a boutique recruiting firm. Dr. Stone completed her PhD in Chemical Biology at the California Institute of Technology, where she developed a novel chemoproteomic tool for studying infection in the laboratory of Professor David Tirrell.
Dr. Stone received her BS in Chemistry at Brown University.
This person is not in any teams
The Column Group
1 followers
The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early-stage drug discovery companies based on their unique scientific platforms and potential to deliver multiple breakthrough therapeutics.